Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway-Reference-Cited by-同舟云学术

Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway

Published:2022-02-01 Issue:2 Volume:13 Page:3526-3536
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Chen Yi¹,Li Xiao²,Xu Jin²,Xiao Hua³,Tang Cuiju⁴,Liang Wei⁴,Zhu Xuedan⁴,Fang Yueyu¹,Wang Hanjin²,Shi Junfeng⁴

Affiliation:

1. Department of Oncology, Nanjing Pukou Central Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

2. Department of Thyroid and Mammary Gland Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

3. Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

4. Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

Funder

Health Science and Technology Development Foundation of Nanjing

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.2018973

Reference49 articles.

1. BMX activates Wnt/β-catenin signaling pathway to promote cell proliferation and migration in breast cancer

2. Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

3. Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway

4. Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells

5. Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of NSD1 Alternative Transcripts in Actin Filament Formation and Cellular Division Pathways in Fibroblasts;Genes;2024-08-24

2. Sotos Syndrome: Deep Neuroimaging Phenotyping Reveals a High Prevalence of Malformations of Cortical Development;American Journal of Neuroradiology;2024-08-15

3. DDX5 deficiency drives non-canonical NF-κB activation and NRF2 expression, influencing sorafenib response and hepatocellular carcinoma progression;Cell Death & Disease;2024-08-09

4. Recent advances in targeting histone H3 lysine 36 methyltransferases for cancer therapy;European Journal of Medicinal Chemistry;2024-08

5. PIP4K2B Protein Regulation by NSD1 in HPV-Negative Head and Neck Squamous Cell Carcinoma;Cancers;2024-03-17